Premature PRV: US FDA Mistakenly Announces Voucher Award For Enzyvant Ahead Of Approval

 
• By Sue Sutter
Starter pistol
US FDA jumped the gun in announcing a voucher award for Enzyvant's still unapproved treatment for congenital athymia. • Source: Alamy

More from Rare Diseases

More from Pink Sheet